Pangen Biotech (XKRX:222110) Marketable Securities : ₩2 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Pangen Biotech Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Pangen Biotech's Marketable Securities for the quarter that ended in Mar. 2024 was ₩2 Mil.

Pangen Biotech's annual Marketable Securities declined from Dec. 2021 (₩15,199 Mil) to Dec. 2022 (₩2 Mil) but then increased from Dec. 2022 (₩2 Mil) to Dec. 2023 (₩149 Mil).

Pangen Biotech Marketable Securities Historical Data

The historical data trend for Pangen Biotech's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pangen Biotech Marketable Securities Chart

Pangen Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

20,000.00

10,549.97

15,198.63

2.00

149.24

Pangen Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															2.00	842.85	146.01	149.24	2.00

Pangen Biotech Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Pangen Biotech (XKRX:222110) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Pangen Biotech Marketable Securities Related Terms

Thank you for viewing the detailed overview of Pangen Biotech's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Pangen Biotech (XKRX:222110) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pangen Biotech Inc (XKRX:222110) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

4Floor Innoplex 2-dong, 306 Sinwon-ro, Yeongtong-gu, Gyeonggi-do, Suwon-si, KOR, 16675

Website

http://www.pangen.com

Pangen Biotech Inc is a biotechnology company. It is engaged in development of biosimilar products and technology transfer services for biologics development. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc.

Pangen Biotech (XKRX:222110) Headlines

No Headlines